| 361.08 1.97 (0.55%) | 02-20 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term | |
|||
| Targets | 6-month : | 437.83 | 1-year : | 511.39 |
| Resists | First : | 374.85 | Second : | 437.83 |
| Pivot price | 357.81 |
|||
| Supports | First : | 345.9 | Second : | 328.01 |
| MAs | MA(5) : | 360.24 |
MA(20) : | 356.74 |
| MA(100) : | 343.95 |
MA(250) : | 308.29 |
|
| MACD | MACD : | 3.1 |
Signal : | 3 |
| %K %D | K(14,3) : | 68.5 |
D(3) : | 68.4 |
| RSI | RSI(14): 54.3 |
|||
| 52-week | High : | 377.54 | Low : | 240.17 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ COR ] has closed below upper band by 40.2%. Bollinger Bands are 11.5% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 361.53 - 363.28 | 363.28 - 364.79 |
| Low: | 352.01 - 354.05 | 354.05 - 355.81 |
| Close: | 358.02 - 361.19 | 361.19 - 363.92 |
Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes generic and injectable pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; distributes plasma and other blood products, vaccines, and other specialty pharmaceutical products; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and other services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; sales force services to manufacturers; and offers other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment provides international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals; and offers specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was founded in 1871 and is headquartered in Conshohocken, Pennsylvania.
Fri, 20 Feb 2026
Insider Sell: Robert Mauch Sells Shares of Cencora Inc (COR) - GuruFocus
Wed, 18 Feb 2026
How Cencora’s (COR) Shift to Long-Term Notes for OneOncology Has Changed Its Investment Story - simplywall.st
Wed, 18 Feb 2026
Cencora, Inc. (COR) Announces Merger of MWI Animal Health with C - GuruFocus
Wed, 18 Feb 2026
Cencora to Receive $1.25B Cash, $2.25B Equity for MWI in $3.5B Deal; Retains 34.3% Stake - TradingView
Wed, 18 Feb 2026
Cencora to refocus on drug distribution with $3.5 billion divestiture of animal health unit - Reuters
Wed, 18 Feb 2026
Animal health shake-up: Covetrus and MWI plan $3.5B merger - Stock Titan
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NYSE
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Distribution
|
|
| Shares Out | 194 (M) |
| Shares Float | 186 (M) |
| Held by Insiders | 4.2 (%) |
| Held by Institutions | 96.3 (%) |
| Shares Short | 4,890 (K) |
| Shares Short P.Month | 4,880 (K) |
| EPS | 8.11 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 7.78 |
| Profit Margin | 0.4 % |
| Operating Margin | 1.1 % |
| Return on Assets (ttm) | 3.2 % |
| Return on Equity (ttm) | 123.7 % |
| Qtrly Rev. Growth | 5.9 % |
| Gross Profit (p.s.) | 58.19 |
| Sales Per Share | 1656.42 |
| EBITDA (p.s.) | 24.79 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 3,880 (M) |
| Levered Free Cash Flow | 3,280 (M) |
| PE Ratio | 44.46 |
| PEG Ratio | 0 |
| Price to Book value | 46.41 |
| Price to Sales | 0.21 |
| Price to Cash Flow | 18.05 |
| Dividend | 0.6 |
| Forward Dividend | 0 |
| Dividend Yield | 0.1% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|